Zhejiang Pharmaceutical Co., Ltd. is a large-scale joint-stock comprehensive pharmaceutical enterprise established in May 1997. In August 1999, with the approval of the China Securities Regulatory Commission, the company publicly issued 58 million RMB A-shares to the public. In October of the same year, the company's shares were listed on the Shanghai Stock Exchange. As of the end of 2018, the registered capital was 960 million yuan and total assets were 10 billion yuan. Zhejiang Pharmaceutical currently owns Xinchang Pharmaceutical Factory, Vitamin Factory, Changhai Biological Branch, Zhejiang Laiyi Biotechnology Co., Ltd., Zhejiang Laiyi Pharmaceutical Co., Ltd., Zhejiang Innovation Biotechnology Co., Ltd., Zhejiang Changhai Pharmaceutical Co., Ltd., and Shanghai Viale Health Management Co., Ltd., Zhejiang Xinma Biopharmaceutical Co., Ltd., nine major branches (subsidiaries) and two R&D units, including the Pharmaceutical Industry Research Institute and Shanghai Laiyi Biopharmaceutical Research and Development Center, with more than 6,800 employees, including various types of There are more than 2,500 professional and technical personnel, accounting for more than 37% of the total number of employees.

Basic Introduction

Business Type Manufacturer

Location 中国浙江省绍兴市

Year Established 1997-05-16

Total Employees 36

Total Annual Revenue -

Main Products Pharmaceutical production (see the license for the specific scope), hazardous chemicals business (see the "Hazardous Chemicals Business License of the People's Republic of China" for the detailed scope), food production (limited to branches operating with a license), food business (operating with a license) ), enterprise management services, technical consultation, technical services, technology development of chemical technology, chemical products (excluding dangerous goods and precursor chemicals), feed additives, sanitary materials, pharmaceutical machinery, consumer products, cosmetics, chemical reagents (excluding dangerous goods), medical equipment (limited to domestically produced Category I) sales, technology development, import and export business, processing of imported materials and "three to one supplement" business. The following branches operate with valid licenses: production of food additives, feed additives, additive premixed feed, industrial hydrogen (qualified products), production, storage and freight of hazardous chemicals, pharmaceutical operations, retail of pre-packaged food; health food Production. (Projects that require approval according to law can only be carried out with the approval of relevant departments)

Main Market -